Kurm Pharma ApS: Financial statements 2018
CVR: 39181274
Source: annual report 2018, Danish Business Authority
18/12/2017 – 31/12/2018
Kurm Pharma ApS (CVR 39181274) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 494,249 and a net result of DKK 347,758. Equity in the 2018 report amounted to DKK 397,758. The solvency ratio was 12.7%.
- Gross Profit
- DKK 494,249
- Profit/Loss
- DKK 347,758
- Equity
- DKK 397,758
- Total Assets
- DKK 3,127,068
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of January 11, 2018, Kvist & Jensen Statsautoriseret Revisionspartnerselskab has been appointed auditor of Kurm Pharma ApS.
As of January 11, 2018, KVIST & JENSEN, GRENAA STATSAUTORISEREDE REVISORER A/S has stepped down as auditor of Kurm Pharma ApS.
As of January 5, 2018, Jacob Gjelstrup has joined the board of directors of Kurm Pharma ApS.
As of January 5, 2018, Jesper Gjelstrup has joined the board of directors of Kurm Pharma ApS.
As of January 5, 2018, Johannes Gjelstrup has joined the board of directors of Kurm Pharma ApS.
As of January 5, 2018, Peter Vammen has joined the board of directors of Kurm Pharma ApS.
As of January 5, 2018, Steen Nordstrøm has joined the board of directors of Kurm Pharma ApS.
About Kurm Pharma ApS
Kurm Pharma ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 2017. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The management consists of Jacob Gjelstrup and Jesper Gjelstrup. The board consists of Steen Nordstrøm (chair), Allan Christensen, Jacob Gjelstrup and Jesper Gjelstrup. The company is owned by Fitzrovia ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -2,598,150 and a net result of DKK -1,978,646 compared with DKK 602,189 the year before. Equity in the 2025 report amounted to DKK 1,813,033.